BackBetter Therapeutics Overview

Better Therapeutics Current Cash

Latest current cash for MCAD: $6.6M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$6.60M
↓ 70.42% YoYΔ $-15.71M vs prior year quarter

Peer average

Loading

Better Therapeutics Current Cash History

Loading

Better Therapeutics vs. peers: Current Cash Comparison

Loading

Better Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Better Therapeutics (MCAD) FAQ

Better Therapeutics posts a current cash of $6.6M as of September 2023. That compares with $22M in the prior-year period — down 70.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Better Therapeutics's current cash was $22M. The latest reading is $6.6M — a 70.4% year-over-year decrease (period ending September 2023). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Better Therapeutics's financial statement story. At $6.6M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for MCAD's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Better Therapeutics's other metric pages and overview cover the third.